Search Results - Encarnación González‐Flores
- Showing 1 - 11 results of 11
-
1
-
2
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018) by M. A. Gómez-España, Javier Gállego, Encarnación González‐Flores, Joan Maurel, David Páez, Javier Sastre, Jorge Aparicio, Manuel Benavides, Jaime Feliú, Ruth Vera
Published 2018Artigo -
3
Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM by Ruth Vera, Encarnación González‐Flores, Carmen Rubio, José Urbano, M. Valero Camps, Juan José Ciampi-Dopazo, J. Orcajo Rincón, V. Morillo, M. A. Gomez Braco, G. Suárez Artacho
Published 2019Artigo -
4
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer by Ariadna Martín-Blázquez, Caridad Díaz, Encarnación González‐Flores, Daniel Franco-Rivas, Cristina Jiménez‐Luna, Consolación Melguizo, José Prados, Olga Genilloud, Francisca Vicente, Octavio Caba, José Pérez del Palacio
Published 2019Artigo -
5
Computed Tomography-Based Sarcopenia and Pancreatic Cancer Survival—A Comprehensive Meta-Analysis Exploring the Influence of Definition Criteria, Prevalence, and Treatment Intentio... by Antonio Jesús Láinez Ramos‐Bossini, Antonio Martínez, David Luengo Gómez, Francisco Valverde‐López, Antonio Gil, Encarnación González‐Flores, Ángela Salmerón Ruíz, Paula María Jiménez Gutiérrez, Consolación Melguizo, José Prados
Published 2025Revisão -
6
Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report... by Eduardo Díaz‐Rubio, Josep Tabernero, Auxiliadora Gómez‐España, Bartomeu Massutí, Javier Sastre, Manuel Chaves-Conde, Alberto Abad, Alfredo Carrato, Bernardo Queralt, Juan José Reina, Joan Maurel, Encarnación González‐Flores, Jorge Aparicio, Fernando Rivera, Ferrán Losa, Enrique Aranda
Published 2007Artigo -
7
Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the... by Javier Sastre, M.L. Maestro, Auxiliadora Gómez‐España, Fernando Rivera, Manuel Valladares, Bartomeu Massutí, Manuel Benavides, Manuel Gallén, Eugenio Marcuello, Albert Abad, A. Arriví, Carlos Fernández-Martos, Encarnación González‐Flores, Josep Tabernero, Marta Vidaurreta, Enrique Aranda, Eduardo Díaz‐Rubio
Published 2012Artigo -
8
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD) by Alfredo Carrato, Albert Abad, Bartomeu Massutí, Cristina Grávalos, P. Escudero, Federico Longo-Muñoz, José-Luís Manzano, Auxiliadora Gómez, María José Safont, Javier Gállego, Beatriz García-Paredes, Carles Pericay, Rosario Dueñas, Fernando Rivera, Ferrán Losa, Manuel Valladares‐Ayerbes, Encarnación González‐Flores, Enrique Aranda
Published 2017Artigo -
9
First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III... by Eduardo Díaz‐Rubio, Auxiliadora Gómez‐España, Bartomeu Massutí, Javier Sastre, Albert Abad, Manuel Valladares, Fernando Rivera, María José Safont, Purificación Martínez de Prado, Manuel Gallén, Encarnación González‐Flores, Eugenio Marcuello, Manuel Benavides, Carlos Fernández-Martos, Ferrán Losa, P. Escudero, A. Arriví, Andrés Cervantes, Rosario Dueñas, Amelia López-Ladrón, Adelaida La Casta, Marta Llanos, Josep Tabernero, Antonio Antón, Enrique Aranda
Published 2012Artigo -
10
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial by Enrique Aranda, José María Viéitez, Auxiliadora Gómez‐España, Silvia Gil Calle, Antonieta Salud, Begoña Graña, Pilar García‐Alfonso, Fernando Rivera, Guillermo Alfonso Quintero-Aldana, Juan José Reina-Zoilo, Encarnación González‐Flores, Mercedes Salgado Fernández, Carmen Guillén‐Ponce, Rocio García‐Carbonero, María José Safont, Adelaida La Casta, Beatriz García-Paredes, Rafael López‐López, Javier Sastre, Eduardo Díaz‐Rubio
Published 2020Artigo -
11
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial by Evelyn Shaw, Josep M. Miró, Mireia Puig‐Asensio, Carles Pigrau, Fernando Barroso-Barcenilla, Javier Murillas, Graciano García‐Pardo, E. Espejo, B. Padilla, Ana García‐Reyne, Juan Pasquau, Jesús Rodríguez‐Baño, Joaquín López‐Contreras, M. Montero, Cristina de la Calle, Vicente Pintado, Esther Calbo, Oriol Gasch, Miguel Montejo, Miguel Salavert, María José García-País, Jordi Carratalà, Miquel Pujol, F. Gudiol, M.Á. Domínguez, Anna Ferrer, Álex Soriano, Manel Almela, G Molas, Nieves Larrosa, Pradeep Sune, Beatriz Mirelis, Ainhoa Rodríguez‐Arias, Julià Gómez, Merçè Espona, J. Tapiol, Laura Canadell, María Victoria García, L. Rumi, Cristina Badía, Mariona Xercavins, Sara Redondo, José L. Pérez, M. Gonzalez, D. Fontanals, Miquel Cruel, Emilia Cercenado, Antonio Mǔr, Telma Sequeira, Fernando Cháves, Víctor Gallego, Elena Loza, Carles Blay, Montserrat Muñoz, Isabel Morales, Marina de Cueto, José M Carretero, M. Perez, I. Muriel Zafra, M. Sota, Amaya Bustinza, Encarnación González‐Flores, J. López, Miguel Perpiñá Tordera, Antoni A Campins, E. Ruiz de Gopegui, Antonio Palomero, Juan Corredoira, F. Garcia, A. Iglesias
Published 2015Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cancer
Oncology
Colorectal cancer
Chemotherapy
Gastroenterology
Oxaliplatin
Surgery
Bevacizumab
Fluorouracil
Biology
Capecitabine
Disease
FOLFIRI
FOLFOX
Irinotecan
Multidisciplinary approach
Radiology
Social science
Sociology
Absolute neutrophil count
Adverse effect
Antibiotics
Bacteria
Biochemistry
Bioinformatics
Biomarker
Biomarker discovery
Circulating tumor cell